HK1214131A1 - 包含氫化可的松的組合物 - Google Patents

包含氫化可的松的組合物

Info

Publication number
HK1214131A1
HK1214131A1 HK16102011.3A HK16102011A HK1214131A1 HK 1214131 A1 HK1214131 A1 HK 1214131A1 HK 16102011 A HK16102011 A HK 16102011A HK 1214131 A1 HK1214131 A1 HK 1214131A1
Authority
HK
Hong Kong
Prior art keywords
hydrocortisone
composition
Prior art date
Application number
HK16102011.3A
Other languages
English (en)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Norbert Poellinger
Annette Grave
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Publication of HK1214131A1 publication Critical patent/HK1214131A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16102011.3A 2013-05-17 2016-02-23 包含氫化可的松的組合物 HK1214131A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1308933.9A GB201308933D0 (en) 2013-05-17 2013-05-17 Paediatric composition
PCT/GB2014/051442 WO2014184525A1 (en) 2013-05-17 2014-05-12 Composition comprising hydrocortisone

Publications (1)

Publication Number Publication Date
HK1214131A1 true HK1214131A1 (zh) 2016-07-22

Family

ID=48746932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102011.3A HK1214131A1 (zh) 2013-05-17 2016-02-23 包含氫化可的松的組合物

Country Status (25)

Country Link
US (1) US9649280B2 (zh)
EP (1) EP2978414B1 (zh)
JP (1) JP6371379B2 (zh)
KR (1) KR102219919B1 (zh)
CN (1) CN105120848B (zh)
AU (1) AU2014267041B2 (zh)
BR (1) BR112015028025B1 (zh)
CA (1) CA2909060C (zh)
CY (1) CY1123284T1 (zh)
DK (1) DK2978414T3 (zh)
ES (1) ES2813382T3 (zh)
GB (2) GB201308933D0 (zh)
HK (1) HK1214131A1 (zh)
HR (1) HRP20201315T1 (zh)
HU (1) HUE050917T2 (zh)
IL (1) IL242275B (zh)
LT (1) LT2978414T (zh)
MX (1) MX2015015759A (zh)
PL (1) PL2978414T3 (zh)
PT (1) PT2978414T (zh)
RS (1) RS60734B1 (zh)
RU (1) RU2664678C2 (zh)
SI (1) SI2978414T1 (zh)
WO (1) WO2014184525A1 (zh)
ZA (1) ZA201507210B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
US20190180872A1 (en) * 2017-12-12 2019-06-13 International Business Machines Corporation Second Opinion Decision Support Using Patient Electronic Medical Records

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE102022T1 (de) 1990-08-30 1994-03-15 Senju Pharma Co Zusammensetzung zur kontrollierten abgabe von medikamenten.
EP0876142B1 (en) 1996-01-16 2001-09-26 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract
KR20040016202A (ko) * 2002-08-16 2004-02-21 주식회사 제이알팜 쓴맛이 차폐된 히드로코르티손 경구용 약제 조성물 및 그제조방법
JP2007533697A (ja) 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US9050249B2 (en) * 2004-04-30 2015-06-09 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition
DE602005022499D1 (de) * 2004-05-31 2010-09-02 Almirall Sa Kombinationen mit Antimuskarin-Wirkstoffen und PDE4-Hemmern
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
RU2290940C2 (ru) * 2004-10-18 2007-01-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская Государственная Медицинская академия" МЗ РФ (ГОУ ВПО НижГМА) Средство для коррекции острой почечной недостаточности при токсическом гепаторенальном синдроме, индуцированном четыреххлористым углеродом, и способ коррекции острой почечной недостаточности при токсическом гепаторенальном синдроме, индуцированном четыреххлористым углеродом
AU2006309295B2 (en) * 2005-06-03 2012-04-26 Elan Pharma International Limited Nanoparticulate acetaminophen formulations
WO2008126076A2 (en) * 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
NZ602010A (en) 2009-04-07 2013-11-29 Duocort Pharma Ab Improved glucocorticoid therapy
ES2683864T3 (es) * 2009-10-01 2018-09-28 Adare Pharmaceuticals, Inc. Composiciones de corticosteroides administradas oralmente
MX2012006240A (es) * 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
CA2799820A1 (en) 2010-05-20 2011-11-24 Duocort Pharma Ab Posology and administration of glucocorticoid based compositions
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
PL2978414T3 (pl) 2020-11-16
LT2978414T (lt) 2020-09-25
KR102219919B1 (ko) 2021-02-25
JP6371379B2 (ja) 2018-08-08
RS60734B1 (sr) 2020-09-30
US9649280B2 (en) 2017-05-16
GB2527233B (en) 2017-07-05
DK2978414T3 (da) 2020-08-24
ES2813382T3 (es) 2021-03-23
CY1123284T1 (el) 2021-12-31
IL242275B (en) 2018-08-30
RU2015150303A (ru) 2017-06-22
BR112015028025A8 (pt) 2019-12-31
GB201516973D0 (en) 2015-11-11
BR112015028025A2 (pt) 2017-07-25
BR112015028025B1 (pt) 2022-11-29
HUE050917T2 (hu) 2021-01-28
CN105120848A (zh) 2015-12-02
AU2014267041A1 (en) 2015-10-15
KR20160011205A (ko) 2016-01-29
MX2015015759A (es) 2016-03-15
CA2909060A1 (en) 2014-11-20
RU2015150303A3 (zh) 2018-03-26
PT2978414T (pt) 2020-08-27
JP2016518439A (ja) 2016-06-23
NZ712756A (en) 2020-12-18
WO2014184525A1 (en) 2014-11-20
HRP20201315T1 (hr) 2020-11-27
EP2978414A1 (en) 2016-02-03
US20160081942A1 (en) 2016-03-24
GB2527233A (en) 2015-12-16
SI2978414T1 (sl) 2020-10-30
GB201308933D0 (en) 2013-07-03
CA2909060C (en) 2020-03-10
EP2978414B1 (en) 2020-07-22
CN105120848B (zh) 2019-06-04
RU2664678C2 (ru) 2018-08-21
ZA201507210B (en) 2017-07-26
AU2014267041B2 (en) 2018-11-22

Similar Documents

Publication Publication Date Title
PL3065569T4 (pl) Kompozycja
EP2889350A4 (en) ADHESIVE COMPOSITION
HK1214088A1 (zh) 油脂組合物
HUE044039T2 (hu) Biokatalitikus készítmény
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322772D0 (en) Composition
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
GB201320303D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
HK1214131A1 (zh) 包含氫化可的松的組合物
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201320675D0 (en) Composition
GB201305622D0 (en) Composition
HUE055185T2 (hu) Kompozíció
GB201321471D0 (en) Composition
GB201321032D0 (en) Composition